Cost‐effectiveness analysis of first‐line treatments for advanced epidermal growth factor receptor‐mutant non‐small cell lung cancer patients

Cancer Medicine ◽

10.1002/cam4.3733 ◽

2021 ◽

Author(s):

Wen‐Qian Li ◽

Ling‐Yu Li ◽

Jin Chai ◽

Jiu‐Wei Cui

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Effectiveness Analysis ◽

Epidermal Growth ◽

Receptor Mutant

Download Full-text

First-line osimertinib in patients with epidermal growth factor receptor–mutant non–small-cell lung cancer and with a coexisting low allelic fraction of Thr790Met

European Journal of Cancer ◽

10.1016/j.ejca.2021.09.039 ◽

2021 ◽

Vol 159 ◽

pp. 174-181

Author(s):

Margarita Majem ◽

Ivanna Sullivan ◽

Santiago Viteri ◽

Guillermo López-Vivanco ◽

Manuel Cobo ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth ◽

Receptor Mutant ◽

Allelic Fraction

Download Full-text

Overall survival of super-elderly (85 years or older) advanced non-small cell lung cancer patients with active epidermal growth factor receptor mutations receiving first-line gefitinib therapy: a single-institute retrospective study

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-020-03344-1 ◽

2020 ◽

Author(s):

Kosuke Kashiwabara ◽

Shinji Fujii ◽

Shinsuke Tsumura ◽

Kazuhiko Sakamoto

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Epidermal Growth Factor Receptor ◽

Retrospective Study ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth

Download Full-text

Thoracic stereotactic body radiation therapy plus first-line tyrosine kinase inhibitors for patients with epidermal growth factor receptor-mutant polymetastatic non-small-cell lung cancer

Medicine ◽

10.1097/md.0000000000027279 ◽

2021 ◽

Vol 100 (37) ◽

pp. e27279

Author(s):

Xia Wang ◽

Zhiqin Lu ◽

Zhimin Zeng ◽

Jing Cai ◽

Peng Xu ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Kinase Inhibitors ◽

Stereotactic Body Radiation Therapy ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth ◽

Receptor Mutant

Download Full-text

First-line gefitinib therapy for elder advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: Multicenter phase II trial (NEJ 003 study).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7561 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7561-7561 ◽

Author(s):

Y. Minegishi ◽

M. Maemondo ◽

S. Okinaga ◽

N. Morikawa ◽

A. Inoue ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Phase Ii Trial ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Multicenter Phase ◽

Epidermal Growth

Download Full-text

Final analysis of phase II trial of carboplatin, S-1, and gefitinib as first-line triplet chemotherapy for advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations

Annals of Oncology ◽

10.1093/annonc/mdx671.032 ◽

2017 ◽

Vol 28 ◽

pp. x136

Author(s):

A. Tanaka ◽

A. Tamiya ◽

M. Tamiya ◽

S. Morita ◽

T. Shiroyama ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Phase Ii Trial ◽

Growth Factor Receptor ◽

Final Analysis ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth

Download Full-text

Heterogeneity and Variation in Resistance Mechanisms Among 223 Epidermal Growth Factor Receptor–Mutant Non–Small Cell Lung Cancer Patients With > 1 Post-Resistance Biopsy

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2017.01.037 ◽

2017 ◽

Vol 98 (1) ◽

pp. 220 ◽

Author(s):

Z. Piotrowska ◽

K. Stirling ◽

R. Heist ◽

M. Campo ◽

C. Rizzo ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Growth Factor Receptor ◽

Resistance Mechanisms ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Receptor Mutant

Download Full-text

Phase II trial of carboplatin, S-1, and gefitinib as first-line triplet chemotherapy for advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations

Medical Oncology ◽

10.1007/s12032-014-0474-x ◽

2015 ◽

Vol 32 (3) ◽

Author(s):

Akihiro Tamiya ◽

Motohiro Tamiya ◽

Takayuki Shiroyama ◽

Nobuhiko Saijo ◽

Takeshi Nakatani ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Phase Ii Trial ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth

Download Full-text

Efficacy of erlotinib and its effects on the quality of life of older patients with epidermal growth factor receptor‐mutant non‐small cell lung cancer: A prospective, multicenter, dose‐modification study

Geriatrics and Gerontology International ◽

10.1111/ggi.14243 ◽

2021 ◽

Author(s):

Yukari Tsubata ◽

Takeshi Masuda ◽

Kosuke Hamai ◽

Masaya Taniwaki ◽

Akari Tanino ◽

...

Keyword(s):

Quality Of Life ◽

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Older Patients ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth ◽

Receptor Mutant

Download Full-text

Real-World Treatment Patterns, Epidermal Growth Factor Receptor (EGFR) Testing and Outcomes in EGFR-Mutated Advanced Non-small Cell Lung Cancer Patients in Belgium: Results from the REVEAL Study

Drugs - Real World Outcomes ◽

10.1007/s40801-021-00243-w ◽

2021 ◽

Author(s):

Kristof Cuppens ◽

◽

Liesbet Lodewyckx ◽

Ingel Demedts ◽

Lore Decoster ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor Receptor ◽

Treatment Patterns ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Reveal Study ◽

Epidermal Growth ◽

Download Full-text

Immune checkpoint inhibitors in epidermal growth factor receptor mutant non-small cell lung cancer: Current controversies and future directions

Lung Cancer ◽

10.1016/j.lungcan.2017.11.009 ◽

2018 ◽

Vol 115 ◽

pp. 12-20 ◽

Author(s):

Ross A. Soo ◽

Sun Min Lim ◽

Nicholas L. Syn ◽

Rebecca Teng ◽

Richie Soong ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Future Directions ◽

Epidermal Growth ◽

Receptor Mutant

Download Full-text